Early Recognition of Chronic Traumatic Encephalopathy through FDDNP PET Imaging
Abstract
The PET biomarker, F-FDDNP (2-(l-{6-[(2-[F-lS]fluoroethyl(methyl)amino]-2-naphthyl} ethylidene) malononitrile) [FDDNP] has shown sensitivity for in vivo detection of tau in addition to I -sheet-containing brain amyloid neuroaggregates. Tau protein in a characteristic distribution is felt to be the cardinal pathologic feature of Chronic Traumatic Encephalopathy. This project will examine whether FDDNP PET imaging correlates with, and/or can predict, decline in cognitive function in those exposed to cumulative head trauma. All operational aspects of this study have been accomplished including local IRB approval, identification of potential subjects from the Profesional Fighters Brain Health Study to rec uit, logistics of the study visit and PET FDDNP imaging, case report forms, and electronic data entry. Actual enrollment of subjects has been delayed awaiting approval from tje Human Research Protection Office.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2014
- Accession Number
- ADA613274
Entities
People
- Charles Bernick